ESMO Congress 2023

Editorial_Generic

Guiding you through the latest cancer research

At the ESMO Congress 2023, our mission with the newspaper articles and expert opinions is to disseminate clear information from the studies presented and help understand their potential impact on cancer care 

    By
  • Alessandra Curioni Fontecedro
Fedro A. Peccatori

Pregnancy after cancer- is it safe?

While increasing evidence from studies support pregnancy after cancer treatment, data gaps persist, particularly regarding the impact of novel therapies on fertility 

By Fedro A. Peccatori
The future of real-world research is now

The future of real-world research is now

ESMO is at the forefront of digital oncology, with some initiatives that support oncologists navigating the emerging opportunities in the field of real-world data research  

The emerging role of ctDNA in breast cancer

The emerging role of ctDNA in breast cancer

Liquid biopsies hold great promise in precision medicine in breast cancer, as shown by the pioneering work of Prof. Nicholas Turner, recipient of the ESMO Award for Translational Research 2023

Three decades of progress in nasopharyngeal cancer

Three decades of progress in nasopharyngeal cancer

Tailored management for high-risk locoregional disease, together with more effective immunotherapy combinations are key areas of exploration in nasopharyngeal cancer, according to 2023 ESMO Lifetime Achievement awardee Prof. Anthony Chan 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.